Andrew R Mendelsohn
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$1.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 24, 2024 | NIH | SBIR Phase I Silencing autoantibody secretion for SLE therapy | $300K | LARIX BIOSCIENCE LLC |
| Sep 21, 2023 | NIH | SBIR Phase I Therapy for ectopic calcification in pseudoxanthoma elasticum | $286K | LARIX BIOSCIENCE LLC |
| May 8, 2023 | NIH | SBIR Phase I Silencing autoantibody secretion for SLE therapy | $300K | LARIX BIOSCIENCE LLC |
| Sep 24, 2022 | NIH | SBIR Phase I Improved carnosic acid congener compounds for Alzheimer’s disease | $326K | LARIX BIOSCIENCE LLC |
| Sep 19, 2022 | NIH | SBIR Phase I Therapeutic antibody for hyperemesis gravidarum | $301K | LARIX BIOSCIENCE LLC |
Peer ranks
Federal funding#1,347
Awards as PI#417
Patents#273
Companies
- LARIX BIOSCIENCE LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.